The US Pharmacopeial Convention (USP) will be organizing a workshop on improving the quality of medicines in the Asia-Pacific region on May 26-28. At the workshop, members of the USP Global Health Impact Program’s Network of Official Medicines Control Laboratories (NOMCoL) Asia-Pacific chapter will learn new and practical analytical techniques, share best practices and discuss ways to sustainably strengthen the capacity of official medicines control laboratories in the region.
USP provides this annual workshop as a platform for NOMCoL Asia-Pacific member countries to resolve shared challenges, report on national advances, and exchange data, insights and lessons learned by facilitating active collaboration and information-sharing across nations and regions, USP aims to advance the sustainable development of official medicines control laboratories (OMCLs) that are capable of producing and sharing harmonized and internationally-recognized data, ensuring the quality of medicines, and combating the proliferation of falsified and substandard drugs..
USP Workshop in Hyderabad:
The workshop will focus on best practices for establishing and maintaining international accreditation; comprehensive methods for analysing the quality of drug samples; novel strategies and tools for increased data transparency and information sharing with laboratories, regulatory authorities and other national and international agencies and techniques to increase laboratory performance and improve drug analyses.
Many experts, including PV Appaji, Director-General, Pharmaceutical Export Promotions Council (Pharmexcil), and PBN Prasad, Deputy Drug Controller-General of India, Central Drugs Standard Control Organisation (CDSCO), will participate in the workshop.
Stay tuned with us for more updates on USP Workshop. Press CTRL+D right now to bookmark this page.